On January 27, 2026, TD Cowen initiated coverage of SI-BONE, a publicly traded medical device company, with a Buy rating. This analyst coverage launch marks a significant moment for the stock, which is generating substantial investor interest. Fintel's latest research platform data reveals crucial i